• Home
  • Product Information
  • Reconstitution
  • Clinical
    • Clinical Safety Profile
    • Adult Studies
    • Adult & Adolescent Studies
    • Pediatric Studies
  • Patient resources
nuwiq.ca nuwiq.ca nuwiq.ca nuwiq.ca
  • Home
  • Product Information
  • Reconstitution
  • Clinical
    • Clinical Safety Profile
    • Adult Studies
    • Adult & Adolescent Studies
    • Pediatric Studies
  • Patient resources

Product Information

Reconstitution Instructions

Clinical Studies

Nuwiq® (Antihemophilic Factor, Recombinant, B-Domain deleted, simoctocog alfa)

Nuwiq® is indicated for the treatment and prophylaxis of bleeding in patients of all ages suffering with hemophilia A (congenital factor VIII deficiency).Nuwiq® is also indicated for the peri-operative treatment of hemophilia A patients.

Patient Resources

Nuwiq® patient brochure, ProCare home care infusion program, reconstitution guide, storage information and cooler bag.

Safety Information

Important safety information, warnings, precautions and how to report suspected adverse events.

    Copyright © 2020 Octapharma I Legal Statement I Privacy Statement I Sitemap
    Octapharma Canada Inc. | 308 - 214 King Street West | Toronto, ON | M5H 3S6

    • enEnglish
    • frFrançais